The role of microbiomes in gastrointestinal cancers: new insights by Aref Yarahmadi, Hamed Afkhami, Hamed Afkhami, Hamed Afkhami

“…Additionally, we delve into the intricate mechanisms through which intestinal microbes influence the efficacy of GI cancer treatments.…”
Get full text

Molecular Determinant of DIDS Analogs Targeting RAD51 Activity by Denis Velic, Alexandre Demeyer, Thibaut Peterlini, Houda Benhelli-Mokrani, Monique Mathé-Allainmat, Jean-Yves Masson, Fabrice Fleury

“…It is shown that overexpression of the RAD51 protein is correlated with increased survival of cancer cells to cancer treatments. For the past decade, RAD51 overexpression-mediated resistance has justified the development of targeted inhibitors. …”
Get full text

Smart Nanotherapeutics and Lung Cancer by Mohammad Doroudian, Mohammad H. Azhdari, Nima Goodarzi, David O’Sullivan, Seamas C. Donnelly

“…This review highlights the most advanced and novel nanotechnology-based strategies, including targeted nanodrug delivery systems, stimuli-responsive nanoparticles, and bio-nanocarriers, which have recently been employed in preclinical and clinical investigations to overcome the current challenges in lung cancer treatments.…”
Get full text

The Role of Genetic Mutations in Mitochondrial-Driven Cancer Growth in Selected Tumors: Breast and Gynecological Malignancies by Ibolya Czegle, Chelsea Huang, Priscilla Geraldine Soria, Dylan Wesley Purkiss, Andrea Shields, Edina Amalia Wappler-Guzzetta

“…Given that there is always room for improvement in cancer treatments and in cancer patient management, it is important to discover new therapeutic targets for affected individuals. …”
Get full text

Optimal CAR T-cell Immunotherapy Strategies for a Leukemia Treatment Model by Evgenii Khailov, Ellina Grigorieva, Anna Klimenkova

“…Although so far, this procedure only helps 50–90% of patients and, like other cancer treatments, has serious side effects. In this work, we have proposed a controlled model for leukemia treatment to explore possible ways to improve immunotherapy methodology. …”
Get full text

THE EFFECTS OF QUALITY OF LIFE ON RECONSTRUCTIVE SURGERY AND EDUCATION OF THE PATIENTS ON BREAST CANCER by Kevser Yeter, Ayşegül Savcı, Fatma Deniz Sayıner

“…The education given about cancer treatments and its side effects make adaptation of patients easier in the following period and decreas psychiatric morbidity. …”
Get full text

<i>Limnospira indica</i> PCC8005 and <i>Lacticaseibacillus rhamnosus</i> GG Mixed Dietary Combination Reduces Pelvic Irradiation-Induced Symptoms in Mice by Sarah-Renée Gholam, Charlotte Segers, Mohamed Mysara, Amelie Coolkens, Sarah Baatout, Natalie Leys, Felice Mastroleo

“…Throughout their cancer treatments, around half of all patients will undergo irradiation that is accompanied by several side effects reducing their quality of life and leading to the interruption or extension of their treatment course. …”
Get full text

Modulation of the Tumor Stroma and Associated Novel Nanoparticle Strategies to Enhance Tumor Targeting by Hessel Haze, Cornelis F. M. Sier, Alexander L. Vahrmeijer, Floris A. Vuijk

“…Modulation of the TME may therefore enhance the efficacy of current cancer treatments and facilitate the development of novel treatment methods as an alternative for invasive resection procedures.…”
Get full text

Radiotherapy–Immunotherapy Combination: How Will We Bridge the Gap Between Pre-Clinical Promise and Effective Clinical Delivery? by Erminia Romano, Jamie Honeychurch, Timothy M. Illidge

“…Radiotherapy (RT) is highly effective at directly killing tumor cells and plays an important part in cancer treatments being delivered to around 50% of all cancer patients. …”
Get full text

Extracellular Vesicles as Drug Targets and Delivery Vehicles for Cancer Therapy by Sai V. Chitti, Christina Nedeva, Raja Manickam, Pamali Fonseka, Suresh Mathivanan

“…Furthermore, we also outline the drawbacks of the existing anti-cancer treatments and the future prospective of EV-based therapeutics.…”
Get full text

A Multidisciplinary Approach to Patients with Psoriasis and a History of Malignancies or On-Treatment for Solid Tumors: A Narrative Literature Review by Nerina Denaro, Gianluca Nazzaro, Giulia Murgia, Federica Scarfì, Carolina Cauchi, Carlo Giovanni Carrera, Angelo Cattaneo, Cinzia Solinas, Mario Scartozzi, Angelo Valerio Marzano, Ornella Garrone, Emanuela Passoni

“…Some patients may continue anti-psoriasis therapy during cancer treatments. Enhanced comprehension of the biological mechanisms in cancer progression and the immune microenvironment of psoriasis holds promise for refining therapeutic strategies. …”
Get full text

Magnetic Nanoparticles Used in Oncology by Veronica Manescu (Paltanea), Gheorghe Paltanea, Iulian Antoniac, Marius Vasilescu

“…Recently, magnetic nanoparticles (MNPs) have more and more often been used in experimental studies on cancer treatments, which have become one of the biggest challenges in medical research. …”
Get full text

Matrix mechanophysical factor: pore size governs the cell behavior in cancer by Muhammad Saif Ur Rahman, Jiaen Wu, Hao Chen, Chengmei Sun, Ying Liu, Shanshan Xu

“…A comprehensive interpretation of ECM pore size would contribute toward a better understanding of the reciprocal interaction between pore size and tumor progression and can be used as a promising target for cancer treatments. In this review, we abridged the knowledge pertaining to (1) ECM and pore size, (2) the importance of pore size and its interplay with cancer, and (3) current advancement in the field of biomaterials to study pore size. …”
Get full text

Biological Aspects of Inflamm-Aging in Childhood Cancer Survivors by Francesca Rossi, Alessandra Di Paola, Elvira Pota, Maura Argenziano, Daniela Di Pinto, Maria Maddalena Marrapodi, Caterina Di Leva, Martina Di Martino, Chiara Tortora

“…Anti-cancer treatments improve survival in children with cancer. …”
Get full text

Epigallocatechin-3-gallate and cancer: focus on the role of microRNAs by Chunguang Wang, Meiling Bai, Zhiguang Sun, Nan Yao, Aiting Zhang, Shengyu Guo, Zatollah Asemi

“…In this review, we aim to provide an overview, based on current knowledge, on how phytochemicals, including epigallocatechin-3-gallate, can be considered as potential miRNAs modulator to improve efficacy of current cancer treatments.…”
Get full text

Novel Therapies Boosting T Cell Immunity in Epstein Barr Virus-Associated Nasopharyngeal Carcinoma by Sarah Renaud, Anthony Lefebvre, Serge Mordon, Olivier Moralès, Nadira Delhem

“…Its high morbidity rate is linked to both late-stage diagnosis and unresponsiveness to conventional anti-cancer treatments. Multiple aetiological factors have been described including environmental factors, genetics, and viral factors (Epstein Barr Virus, EBV), making NPC treatment that much more complex. …”
Get full text

Chitosan–Hyaluronic Acid Nanoparticles for Active Targeting in Cancer Therapy by Lisa Efriani Puluhulawa, I Made Joni, Khaled M. Elamin, Ahmed Fouad Abdelwahab Mohammed, Muchtaridi Muchtaridi, Nasrul Wathoni

“…Cancer is the most common cause of death worldwide; therefore, there is a need to discover novel treatment modalities to combat it. One of the cancer treatments is nanoparticle technology. Currently, nanoparticles have been modified to have desirable pharmacological effects by using chemical ligands that bind with their specific receptors on the surface of malignant cells. …”
Get full text

“HLA-C: evolution, epigenetics, and pathological implications in the major histocompatibility complex” by Erick Velastegui, Edwin Vera, Wim Vanden Berghe, Mindy S. Muñoz, Andrea Orellana-Manzano

“…These alterations can manifest in diseases such as alopecia areata and psoriasis and can also impact susceptibility to cancer and the effectiveness of cancer treatments. By comprehending the intricate interplay between genetic and epigenetic factors that regulate HLA-C expression, researchers may develop novel strategies for preventing and treating diseases associated with HLA-C dysregulation.…”
Get full text

Oxidative Damage as a Fundament of Systemic Toxicities Induced by Cisplatin—The Crucial Limitation or Potential Therapeutic Target? by Jelena S. Katanić Stanković, Dragica Selaković, Gvozden Rosić

“…Despite the progress of pharmaceutical sciences and medicine and the successful application of other platinum complexes for the same purpose, cisplatin is still the therapy of choice in many cancers. Treatment for testicular, ovarian, head and neck, urothelial, cervical, esophageal, breast, and pulmonary malignancies is still unthinkable without the use of this drug. …”
Get full text

Dendritic Cell-Based and Other Vaccination Strategies for Pediatric Cancer by Sévérine de Bruijn, Sébastien Anguille, Joris Verlooy, Evelien L. Smits, Viggo F. van Tendeloo, Maxime de Laere, Koenraad Norga, Zwi N. Berneman, Eva Lion

“…Moreover, in contrast to conventional cancer treatments such as chemotherapy, therapeutic cancer vaccines are designed to specifically target tumor cells and not healthy cells or tissues. …”
Get full text